Introduction
============

*Nepeta* L. (from Lamiaceae) contains about 300 species, which are distributed in central and southern Europe and in near East, central and southern Asia also. Within them Iran is one of the centers of origin of this genus with 75 species and approximately 53% endemics \[[@B1]\]. The diversity, species richness and variation as well as chemical properties have led to much research into this genus. The extracts of many *Nepeta* species are used in domestic medicine. *N. cataria* L., commonly known as catnip, is the most intensively studied species \[[@B2]\], which is used as a fortifier, a disinfectant and a cure for colds. The extracts of some species are also used because of their diuretic properties and slight bacteriostatic activity, and also in ointments to heal skin disorders of eczema type \[[@B3]\]. Some of the species are widely used in folk medicine because of their expectorant, antiseptic, antitussive, antiasthmatic and febrifuge activities \[[@B4]-[@B6]\]. The beverages and infusion prepared from the aerial parts of *Nepeta crispa* Willd. were traditionally used as sedative, relaxant, carminative and also restorative tonic for nervous and respiratory disorders \[[@B7]\]. It has also been shown to have antimicrobial (*N. meyeri*) and anxiolytic (*N. persica*) properties \[[@B8]\].

One of these *Nepeta* plants of Iran is *Nepeta pogonosperma* Jamzad et Assadi, which was identified as new species in 1984 \[[@B6]\]. The essential oil composition of its aerial parts has been reported \[[@B9]\]. The main components of its essential oil were 4aα, 7α, 7aβ-Nepetalactone (57.6%) and 1,8-cineol (26.4%). The dried aerial parts of other species of *Nepeta* were also shown to contain both of these components in different proportion in their essential oil \[[@B7],[@B10]\].

The most important constituent of the essential oil of this *Nepeta* species, 1, 8-cineol, an oxygenated monoterpene, showed inhibitory effect on carrageenan induced paw edema and cotton-pellet induced granuloma in rats \[[@B11]\]. It has also been stated that this terpenoid oxide has strong inhibitory effect on cytokine production in cultured human lymphocytes and monocytes \[[@B12]\]. Moreover, its steroid sparing capacity in bronchial asthma was also determined \[[@B13]\]. A recent report on the essential oil of *Rosmarinus officinalis* L. (a endemic plant in Mexico), which contains 8.58% 1,8-cineole, showed a dose dependent antinociceptive effect in rat model \[[@B14]\]. In addition different isomers of Nepetalactones were reported to have considerable sedative and analgesic activity. 4aα, 7α, 7aβ-Nepetalactone, the key constituent of *Nepeta ceasarea* Boiss, was suggested to have a specific opioid receptor agonistic activity \[[@B15]\]. Again the catnip oil prepared from *Nepeta cataria* showed to have 40% nepetalactone, which was responsible for significant increase in the hexobarbital sleeping time in mice \[[@B16]\].

Different species of Nepeta genus are reported to contain antinociceptive and anti-inflammatory effects. In an study on *Nepeta cataria* essential oil showed of having 79.27% of nepetalactone which might be responsible for its potent antinociceptive and anti-inflammatory activity in mice model \[[@B17]\]. Moreover, extract and fractions from *Nepeta sibthorpil* have been reported to have anti-inflammatory activity in carrageenan induced paw edema model in rat \[[@B18]\]. Recently we reported the analgesic and anti-inflammatory effects of *Nepeta crispa* Willd*.* in animal models \[[@B19]\]. On the basis of these diversified biological activities of the *Nepeta* species and their use in folk medicine, this study was designed to evaluate antinociceptive and anti-inflammatory effects of a newly introduced species*, Nepeta pogonosperma.* We evaluated the antinociceptive effect in both acute and chronic pain models and also investigated its anti-inflammatory activity in an animal paw edema model.

Materials and methods
=====================

Plant materials
---------------

The aerial flowering parts of *Nepeta pogonosperma* Jamzad & Assadi were collected from its wild locality in Qazvin province on 20 May, 2008. The plant was identified by A. Sonboli and a voucher specimen (MPH-1917) was deposited in herbarium of Medicinal Plants and Drugs Research Institute (MPH) of Shahid Beheshti University, Tehran, Iran.

Air-dried aerial parts (100 g) of *Nepeta pogonosperma* were subjected to hydrodistillation using a Clevenger-type apparatus. The essential oil was dried over anhydrous sodium sulfate and stored in sealed vials. The oil was stored at 4°C until the time of analysis and tests. GC-MS analysis of the essential oil was conducted on a Thermoquest-Finnigan Trace GC-MS system equipped with a fused silica DB-1 capillary column (60 m × 0.32 mm i.d., film thickness 0.25 μm). Helium was used as the carrier gas at the constant flow of 1.1 ml/min. The oven temperature was 60°C rising to 250°C at a rate of 5°C/min, then held at 250°C for 10 min; transfer line temperature, 250°C; split ratio was 1/50. The quadrupole mass spectrometer was scanned over the 45--465 amu with an ionizing voltage of 70 eV and an ionization current of 150 μA. The injector and detector (FID) temperatures were kept at 250°C and 280°C, respectively. Retention indices (RI) for all constituents were calculated according to Van den Dool approach, using *n-*alkanes (C~6~ -- C~24~) as standards and the essential oil on a DB-1 column under the same chromatographic conditions. The identification of the components was made based on comparison of their mass spectra with those of the internal computer reference mass spectra libraries (Wiley 7.0), as well as by comparison of their retention indices with data published.

Animals
-------

Twenty four (24) male Wister rats weighing 225 ± 25 g obtained from the Pasteur Institute, Karaj, Iran, were used. They were housed in plexiglass cages as 6 animals per cage with room temperature 24 ± 2°C under a 12 hour light/dark cycle and had free access to water and pellet. The rats were accustomed to the laboratory condition for 4 days before commencement of the experiments. Efforts were made to minimize the number of animals used and their sufferings. All research and animal care procedures were performed according to the international guidelines on the use of laboratory animals and on the basis of codes for ethics in animal research in Tarbiat Modares University

Drug administration
-------------------

Animals were treated intraperitoneally (i.p.) with normal saline for the control group or the essential oil of *Nepeta pogonosperma* at the doses of 50, 100 or 200 mg/kg for the experimental groups. The doses were selected based on our previous report on the antinociceptive effects of *N. crispa*\[[@B19]\]. An equal volume of injection of essential oil or normal saline (200 μl/100 g of body weight) was applied for all animals.

Tail-flick test
---------------

Acute antinociceptive effect was assessed based on the method introduced by D'Amour and Smith \[[@B20]\] using a tail-flick apparatus (Harvard Apparatus). The baseline latency was obtained using the mean of similar three consecutive measurements. Normal saline (for control rats) or essential oil (for experimental groups) were injected i.p. immediately after the third pre-drug measurement. Again, test latency was determined after 30 minutes of saline or oil administration (mean of 3 measurements). To minimize tissue damage, a maximum latency of 10 seconds was imposed. Antinociceptive effect was calculated as percent of maximum possible effect (% MPE), as follows \[[@B21]\]:

$$\%\mspace{9mu}\text{MPE} = \left\lbrack {\left( {\text{TL} - \text{BL}} \right)/\left( {\text{CT} - \text{BL}} \right)} \right\rbrack \times 100$$

TL = Test latency; BL = Baseline latency; CT = Cut-off time.

Formalin test
-------------

The formalin test was carried out in a plexiglass observation box, with a mirror placed under the floor (at a 45^o^ angle) to allow a clear view of the paws. Immediately after the recording of the 3rd latency time of the tail flick test, 50 μl of 2% formalin was injected subcutaneously into the plantar aspect of the rat's right hind paw. The animal was then placed in the observation cage and pain behaviors were recorded for 60 minutes. Nociception was rated using a modification of the original formalin test protocol \[[@B22]\]. Briefly, the pain scoring measurements were as follows: 0 = normal weight bearing on the injected paw; 1 = limping during locomotion or resting the paw lightly on the floor; 2 = elevation of the injected paw; and 3 = licking or biting of the injected paw. The first 5 minutes was considered as early phase and minutes 16 to 60 were considered as the late phase of formalin test \[[@B23]\]. The different behavioral parameters including jerking, flexing and licking were took out from the records as total counts per 5 minutes or total duration in seconds per 5 minutes, respectively.

Anti-inflammatory test
----------------------

Anti-inflammatory effects of the essential oil were determined by the formalin-induced paw edema model. The amount of paw edema caused by intra-plantar injection of 2% formalin was used as an indicator of inflammation severity. Following 60 minutes of recording the pain behaviors (about 90 minutes after the i.p administration of the essential oil or saline), the animal was sacrificed. Then the volume of the animals' right and left hindpaws were measured using a water plethysmometer as mentioned by Fereidoni *et al.* 2001 \[[@B24]\]. Right paw volume was subtracted by left paw volume to obtain the net edema volume.

The rats were not tested more than once and all the experiments were carried out in between 9:00 and 15:00, to minimize the possible influence of circadian changes on rat behavior.

Statistical analysis
--------------------

Data obtained for different pain behavior and edema were scrutinized using one way analysis of variance (ANOVA) followed by the Tukey post-hoc test. The results are expressed as mean ± S.E.M and p \<0.05 was considered as significant difference of means.

Results
=======

Essential oil composition
-------------------------

Although, the main components of *Nepeta pogonosperma* essential oil were reported to be 1,8-cineole and 4aα,7α,7aβ-nepetalactone, concerning the percentage variations in previous reports and the seasonal and local variations in the component of different plants, we analyzed the composition of essential oil applied in this study. Hydrodistilled essential oil of aerial parts of *NP* gave pale yellow oil and forty-one components were identified representing 97.5% of the total oil. Essential oil compounds are presented in Table [1](#T1){ref-type="table"}, where compounds are listed in order of their elution on the DB-1 column. The main components of the oil were 4aα,7α,7aα --nepetalactone (14.5%) and 1,8- cineole (31.2%) followed by α-terpineol (5.4%), (E)-α-bisabolene (5.4%), terpinen-4-ol (4.8%), linalool (4.5%) and β-pinene (3.5%).

###### 

**Essential oil composition of*Nepeta pogonosperma***

  **Compound**                        **RI**      **%**
  --------------------------------- ---------- -----------
  α-thujene                            925         0.3
  α-pinene                             933         1.4
  Sabinene                             968         0.7
  **β-pinene**                       **974**     **3.5**
  Myrcene                              983         0.7
  isobutyl 2-methylbutanoate           993         0.5
  isobutyl isovalerate                 995         0.9
  *p*-cymene                           1017        2.7
  **1,8-cineole**                    **1030**   **31.2**
  γ-terpinene                          1050        0.4
  *trans*-sabinene hydrate             1059        2.1
  *cis*-linalool oxide                 1064        0.3
  **Linalool**                       **1089**    **4.5**
  2-methylbutyl 2-methylbutanoate      1093        0.7
  2-methylbutyl isovalerate            1096        0.3
  4-acetyl-1-methyl-1-cyclohexene      1112        0.8
  *trans*-pinocarveol                  1129        0.8
  Pinocarvone                          1144        0.8
  δ-terpineol                          1153        3.1
  **terpinen-4-ol**                  **1167**    **4.8**
  **α-terpineol**                    **1179**    **5.4**
  Geraniol                             1240        0.5
  4aβ-7α-7aα-nepetalactone             1325        0.3
  **4aα-7α-7aα-nepetalactone**       **1336**   **14.5**
  4aα-7α-7aβ-nepetalactone             1346        0.3
  4aβ-7α-7aβ-nepetalactone             1361        0.5
  geranyl acetate                      1364        3.1
  β-bourbonene                         1383        0.8
  trans-caryophyllene                  1417        1.1
  (E)-β-farnesene                      1447        0.7
  α-humulene                           1450        0.8
  germacrene D                         1475        0.2
  **(*E*)-α-bisabolene**             **1493**    **5.2**
  caryophyllene-oxide                  1573        2.7
  humulene epoxide                     1597        0.9
  Monoterpene hydrocarbons                         9.7
  Oxygenated monoterpens                          72.2
  Sesquiterpene hydrocarbons                       8.8
  Oxygenated sesquiterpenes                        3.6
  Others                                           3.2
  Total identified (35 comp.)                   **97.5%**

Tail-flick test
---------------

The effects of 50, 100 and 200 mg/kg doses of *NP* essential oil on acute pain were evaluated using tail flick test. As evaluated at 30 minutes post injection, 50 mg/kg dose of NP did not produce any significant analgesia, but the doses of 100 and 200 mg/kg of NP reduced the acute thermal pain significantly (p \<0.01 and p \<0.001, respectively). The percentage of maximum possible effect (% MPE) of all the doses were compared to that of the control and presented in Figure [1](#F1){ref-type="fig"}.

![**Antinociceptive effects of different doses (i.p.) of the essential oil of*Nepeta pogonosperma*(NP) on tail flick latency.** Comparison was done on percentage of maximum possible effect (%MPE). Each bar represents the mean ± S.E.M. of 6 rats. \* = p \<0.05, \*\* = p \<0.01 compared to control.](2008-2231-20-48-1){#F1}

Formalin test
-------------

The effects of systemic i.p. administration of different doses of the essential oil of *NP* on the early and late phases of formalin test were observed. In both phases the pain behaviors were separately analyzed as total jerking frequency, licking duration and flexing duration.

As it is mentioned in Figure [2](#F2){ref-type="fig"}, in the first phase of formalin test 50, 100 and 200 mg/kg doses of NP reduced the jerking frequency (p \<0.001, in all doses), flexing duration (p \<0.05, p \<0.05, p \<0.01, respectively) and licking duration (p \<0.05, p \<0.001, p \<0.001, respectively), significantly.

![**Antinociceptive effects of different doses of the essential oil of*Nepeta pogonosperma*(NP) in the early phase of formalin test (minutes 0 -- 5).** NP doses reduced different pain behaviors including jerking (**A**), flexing (**B**) and licking (**C**). Each bar symbolizes for mean ± S.E.M. for 6 rats. \* = p \<0.05, \*\* = p \<0.01, \*\*\* = p \<0.001 compared to control.](2008-2231-20-48-2){#F2}

Again in the late phase of formalin test, as it is mentioned in Figure [3](#F3){ref-type="fig"}, all the doses of NP reduced the jerking frequency (p \<0.001, in all doses), the flexing duration (p \<0.001, p \<0.01, p \<0.001, respectively) and licking duration (p \<0.01, p \<0.05, p \<0.001, respectively), significantly.

![**Antinociceptive effect of different doses of the essential oil of*Nepeta pogonosperma*(NP) in the late phase of formalin test (minutes 16 -- 60).** NP doses reduced all pain behaviors including jerking (**A**), flexing (**B**) and licking (**C**). Each bar symbolizes for mean ± S.E.M. for 6 rats. \* = p \<0.05, \*\* = p \<0.01, \*\*\*p \<0.001 compared to control.](2008-2231-20-48-3){#F3}

Anti-inflammatory effect
------------------------

The amount of edema for formalin injected paw was measured at the end of formalin test. As illustrated in Figure [4](#F4){ref-type="fig"}, all the doses of the oil showed anti-inflammatory effect in the paw edema model though it was significant only in 100 (p \<0.01) and 200 (p \<0.05) mg/kg of doses of NP.

![**Anti-inflammatory effects of different doses of the essential oil of*Nepeta pogonosperma*(NP) in formalin-induced paw edema model.** Each bar represents for mean ± S.E.M., n = 6 (experimental) - 9 (control) rats, \* = p \<0.05, \*\* = p \<0.01, compared to control.](2008-2231-20-48-4){#F4}

Discussion
==========

The management of pain is probably one of the most common and yet most difficult aspects in medical practice. Many improved analgesics and anti-inflammatory agents have been developed, but there is considerable opportunity for conceptual innovation.

We used heat induced and formalin induced pain model for evaluating antinociceptive and formalin induced paw edema model for anti-inflammatory effect of *Nepeta pogonosperma* in experimental rats. Our data demonstrated that the essential oil of this plant elicited potent antinociceptive effects in rats subjected to both the acute thermal (tail-flick) and chronic or persistent formalin pain stimuli and strong anti-inflammatory effect to formalin induced paw edema model.

The Tail flick test is one of the most appropriate techniques to assess the acute somatosensory pain transmission by stimulating thermoreceptors in experimental animal model \[[@B25]\]. King *et al* (1997) showed that this test is sensitive to centrally acting analgesics and supraspinal systems facilitated this tail flicking response which was inhibited by a low dose of morphine \[[@B26]\]. Since our results mentioned potent analgesia in higher two doses of NP in tail flick test, it may be commented that the effective component(s) of this essential oil exerts its antinociceptive effect by modulating the pain transmission in the central nervous system.

Formalin test is one of the appropriate methods for producing and quantifying the chemical pain in the rat model. Pain intensity in this test is dependent on some objective behavioral categories and the observations are converted to numerical values \[[@B22]\]. Subcutaneous injection of formalin induces hindpaw inflammation, which leads to a response characterized by jerking, flexing followed by licking of the affected hindlimb. This characteristic response is considered to be a central nociceptive model, and has been associated with increased levels of chemical mediators in tissue fluids. The level of pain in this model is sensitive to both centrally and peripherally acting analgesics. In the present study, as the i.p. administration of different doses of the essential oil of *NP* inhibited both phases of pain response relative to controls, it may be suggested that it has both the central and peripheral antinociceptive effects. We checked for anti-inflammatory effect of the essential oil and observed reduced formalin induced edema. This finding proved the peripheral antinociceptive effects of the oil bye ameliorating the formalin induced inflammation. Comparing the antinociceptive and anti-inflammatory effects of the lower dose (50 mg/kg), again makes the central analgesic effect plausible. In the other word, the dose which did not produce anti-inflammatory effect exerted significant analgesic effect.

Similar to the previous report \[[@B9]\], NP essential oil contained 1, 8-cineole and 4aα, 7α, 7aβ-Nepetalactone as two major constituent*.* It has been suggested by many investigators that 1, 8-cineole, the most important constituent of *NP* essential oil has potent antinociceptive \[[@B14]\] and anti-inflammatory activity \[[@B11],[@B12]\]. In addition, Aydin and colleagues (1998) suggested that 4aα, 7α, 7aβ-Nepetalactone, might be responsible for the significant analgesic activity and marked sedation in a rat model. They also recommended this nepetalactone might have specific opioid receptor subtype agonist activity \[[@B15]\]. Again in a behavioral study on rats a significant decrease in performance was observed following i.p. administration of nepetalactone enriched fraction \[[@B16]\]. Furthermore the nepetalactone isomers were suggested to be the responsible component of the anti-nociceptive and anti-inflammatory actions of *Nepeta cataria* L. var. citriodora (Becker) Balb. \[[@B17]\]. Moreover, the essential oil of *Nepeta crispa* Willd. which contained 20.3% 4aα, 7α, 7aβ-Nepetalactone and 47.9% 1,8-cineole, showed strong antibacterial, antifungal, antinociceptive and antiinflammatory activity \[[@B19],[@B21]\]. This finding may support the potent anti-inflammatory activity observed in our present experiment. In a previous study, the analgesic activity of the essential oil of *Nepeta italica* L. was showed to be correlated with the amount of 1, 8-cineole \[[@B27]\]. In a recent animal study, cineole has been recommended to reveal an antinociceptive activity comparable to that of morphine in thermal analgesic stimuli \[[@B28]\]. Hence, both of the components of *NP* essential oil, the 4aα, 7α, 7aβ-Nepetalactone and 1, 8-cineole, may be responsible for our experimental findings.

Conclusion
==========

In conclusion, it may be recommended that the essential oil of *Nepeta pogonosperma* may minimize both the acute and chronic forms of nociception and may have potent role against inflammation, but the dose should be maintained precisely to obtain the intended effect. Although, further experimental study is needed to elucidate the exact component and mechanism responsible for these effects.
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